Salahaldeen Ismail Mohammed

Salahaldeen Ismail Mohammed

Auto-generated profile, based on publicly available information

Salahaldeen Ismail Mohammed

Faculty of Medical Laboratory Sciences, Department of Medical Microbiology Omdurman Islamic University Khartoum Sudan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2022 in Interdisciplinary Perspectives on Infectious Diseases
Verified
Journal Article
Open access
PDF file
MAMohammed Shams Aldeen
Mohammed Shams Aldeen
MMMusa Logman Masaad
Musa Logman Masaad
AAAyman Azhary
Ayman Azhary
ASAbdulomez Suliman
Abdulomez Suliman
MAMohammed Ahmed Alziber
Mohammed Ahmed Alziber
MHMohammed Elfatih Hamida
Mohammed Elfatih Hamida
Patients infected with COVID-19 are at an increased risk for thrombosis, suggesting a possible role of COVID-19 in the induction of coagulopathy. This study aimed to investigate the presence of prothrombotic antineutrophil cytoplasmic antibodies (ANCA) and antiphospholipid antibodies (aPLs) in the course of COVID-19 infection and to correlate these markers with severity and fatality, suggesting that COVID-19-induced autoimmune thrombosis is a possible axis in the inflammatory circuit of this infection. To investigate this, we conducted a case-control study which included patients with a positive reverse transcription-polymerase chain reaction (RT-PCR) test of COVID-19 and a control group with negative COVID-19 PCR and antibody (IgG-IgM and IgA nucleoprotein) ELISA results. An indirect immunofluorescence assay using granulocyte biochips (Aesku slides from AESKU DIAGNOSTICS, Germany) was used to detect ANCA (IgG), as well as multiplex ELISA for the detection of antiphospholipid antibodies for all patients with COVID-19 and for the control group. The results revealed the detection of antiphospholipid antibodies (IgG) in one patient out of the 45 patients in the case group. 1/45(2.2%) and 7/45(15.6%) tested positive for ANCA. Five were men and two were females, with one case revealed to be positive for both aPL and ANCA. A cytoplasmic reaction on the eosinophil granulocytes was observed in 2 cases; both were positive for ANCA. Other markers (CRP, APTT, PT, INR, ESR, and neutrophil and lymphocyte counts) were included in the study, along with demographic data. No aPL or ANCA reactions were detected for any of the control groups. These findings suggest that aPL and ANCA may be induced during the course of inflammation in COVID-19 and possibly contribute to the disease’s severity and mortality.

14 November 2025 in Clinical Case Reports
Verified
Journal Article
Open access
AAAyman Azhary
Ayman Azhary
Nooh Mohamed HajhamedNooh Mohamed Hajhamed
Nooh Mohamed Hajhamed
SMSalahaldeen Ismail Mohammed
Salahaldeen Ismail Mohammed
This letter highlights the critical need for clinicians to understand antinuclear antibody (ANA) testing methodologies and autoantibody specificities to prevent diagnostic errors and accurately applying classification criteria. Anti‐Ro52 is an antinuclear antibody whose detection fulfills the 2019 EULAR/ACR classification entry criterion.